Insider Transactions Reported by 20 Insiders of PLIANT THERAPEUTICS, INC.

Symbol
PLRX on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

PLIANT THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $68,438,025 29 Nov 2022
Hans Hull Chief Business Officer $2,920,870 23 Jan 2025
Eric Lefebvre Chief Medical Officer $2,640,879 23 Jan 2025
Mike Ouimette General Counsel & Corp. Sec'y $1,160,287 23 Jan 2025
Bernard Coulie President and CEO, Director $1,146,535 -$114,400 -9.1% 22 Jan 2026
Keith Lamont Cummings Chief Financial Officer $380,433 -$30,723 -7.5% 22 Jan 2026
Steve E. Krognes Director $111,338 05 Jun 2025
Lily Cheung Chief Human Resource Officer $57,404 -$9,644 -14% 22 Jan 2026
DAVID E. I. PYOTT Director $55,669 05 Jun 2025
GAYLE A. CROWELL Director $55,669 05 Jun 2025
Thomas A. MCCOURT Director $55,669 05 Jun 2025
Suzanne Louise Bruhn Director $55,669 05 Jun 2025
Smital Shah Director $55,669 13 Jun 2024
M.D. Ph.D. Hoyoung Huh Director $55,669 05 Jun 2025
John T. Curnutte Director $55,669 05 Jun 2025
Darren S. Cline Director $55,669 05 Jun 2025
Katharine Knobil Director $55,669 05 Jun 2025
Minnie Kuo Chief Operating Officer $48,391 -$8,854 -15% 22 Jan 2026
Neil Exter Director 16 Jun 2022
CHARLES J. HOMCY Director 29 Jun 2021

Recent Insider Transactions by Companies or Individuals for PLIANT THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.